Put Options

19 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$19.97 - $24.53 $5,991 - $7,359
300 Added 10.34%
3,200 $71,000
Q3 2023

Nov 14, 2023

BUY
$24.36 - $28.18 $70,644 - $81,722
2,900 New
2,900 $71,000
Q3 2022

Nov 14, 2022

BUY
$19.51 - $34.14 $115,109 - $201,426
5,900 New
5,900 $167,000
Q2 2022

Aug 08, 2022

SELL
$17.06 - $31.42 $380,438 - $700,666
-22,300 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$26.68 - $34.81 $432,216 - $563,922
16,200 Added 265.57%
22,300 $649,000
Q4 2021

Feb 14, 2022

BUY
$29.58 - $49.78 $100,572 - $169,252
3,400 Added 125.93%
6,100 $201,000
Q3 2021

Nov 15, 2021

BUY
$41.92 - $58.18 $113,184 - $157,086
2,700 New
2,700 $125,000
Q1 2021

May 17, 2021

SELL
$44.23 - $57.5 $163,651 - $212,750
-3,700 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$33.21 - $46.54 $122,877 - $172,198
3,700 New
3,700 $160,000
Q3 2020

Nov 16, 2020

SELL
$33.87 - $55.93 $633,369 - $1.05 Million
-18,700 Closed
0 $0
Q2 2020

Aug 14, 2020

SELL
$34.45 - $53.48 $192,920 - $299,488
-5,600 Reduced 23.05%
18,700 $1 Million
Q1 2020

May 15, 2020

BUY
$31.52 - $53.81 $441,280 - $753,340
14,000 Added 135.92%
24,300 $862,000
Q4 2019

Feb 14, 2020

SELL
$30.08 - $50.59 $394,048 - $662,729
-13,100 Reduced 55.98%
10,300 $492,000
Q3 2019

Nov 14, 2019

BUY
$32.4 - $49.58 $336,960 - $515,632
10,400 Added 80.0%
23,400 $758,000
Q2 2019

Aug 14, 2019

SELL
$46.17 - $68.1 $323,190 - $476,699
-7,000 Reduced 35.0%
13,000 $648,000
Q1 2019

May 15, 2019

SELL
$45.92 - $67.67 $546,448 - $805,273
-11,900 Reduced 37.3%
20,000 $1.35 Million
Q4 2018

Feb 14, 2019

BUY
$42.73 - $76.53 $1.05 Million - $1.88 Million
24,600 Added 336.99%
31,900 $1.47 Million
Q3 2018

Nov 14, 2018

BUY
$71.67 - $91.95 $401,352 - $514,920
5,600 Added 329.41%
7,300 $563,000
Q2 2018

Aug 14, 2018

BUY
$73.22 - $99.55 $124,474 - $169,235
1,700 New
1,700 $143,000

Others Institutions Holding AGIO

About AGIOS PHARMACEUTICALS, INC.


  • Ticker AGIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 54,818,000
  • Market Cap $3.24B
  • Description
  • Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...
More about AGIO
Track This Portfolio

Track Walleye Trading LLC Portfolio

Follow Walleye Trading LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Trading LLC with notifications on news.